Risk factors in the development of cytomegalovirus-related pneumonia in renal transplant recipients.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMID 6317769)

Published in J Infect Dis on December 01, 1983

Authors

P K Peterson, H H Balfour, D S Fryd, R Ferguson, R Kronenberg, R L Simmons

Articles by these authors

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med (1997) 17.51

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med (1990) 12.00

Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol (1975) 8.06

Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer (1979) 5.60

Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science (1996) 4.72

Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria. J Immunol Methods (1977) 3.89

Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science (1992) 3.80

Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut (1982) 3.68

Survival of influenza viruses on environmental surfaces. J Infect Dis (1982) 3.51

Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med (1992) 3.42

Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) (1980) 3.42

Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Engl J Med (1993) 3.34

Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A (1993) 3.24

Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect Immun (1978) 3.23

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg (1983) 3.15

Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes. J Infect Dis (1977) 3.09

Use of medical emergency team responses to reduce hospital cardiopulmonary arrests. Qual Saf Health Care (2004) 3.00

Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol (1992) 2.92

The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest (1978) 2.83

Effect of protein A on staphylococcal opsonization. Infect Immun (1977) 2.79

A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med (1989) 2.78

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med (1989) 2.77

Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology (1999) 2.75

Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Ann Intern Med (1990) 2.53

Bacterial adherence to fibronectin and endothelial cells: a possible mechanism for bacterial tissue tropism. J Lab Clin Med (1984) 2.52

Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med (1989) 2.49

Immunodepression after major surgery in normal patients. Surgery (1975) 2.48

Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci U S A (1993) 2.46

Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44

Failure of automatic control of ventilation (Ondine's curse). Report of an infant born with this syndrome and review of the literature. Medicine (Baltimore) (1970) 2.44

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44

The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40

Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation (1985) 2.34

An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med (1989) 2.27

Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25

Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg (1991) 2.24

Rapid and sensitive viral culture method for human immunodeficiency virus type 1. J Clin Microbiol (1988) 2.22

Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. J Infect Dis (1997) 2.18

Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers. Infect Immun (1979) 2.17

Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis (1988) 2.16

Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol (1990) 2.11

Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria. Am J Pathol (1985) 2.08

Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol (1991) 2.07

Localization of the third component of complement on the cell wall of encapsulated Staphylococcus aureus M: implications for the mechanism of resistance to phagocytosis. Infect Immun (1979) 2.07

Activation of complement by cell surface components of Staphylococcus aureus. Infect Immun (1978) 2.03

Fibreoptic endoscopic palliative intubation of inoperable oesophagogastric neoplasms. Br Med J (1977) 2.03

Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement. J Immunol (1982) 2.02

Chemiluminescence response of phagocytizing human monocytes. Infect Immun (1976) 2.01

Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg (1998) 2.00

Tube introducer and modified Celestin tube for use in palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut (1978) 2.00

Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. J Clin Microbiol (1992) 1.99

Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages. Infect Immun (1981) 1.97

Inhibition of alternative complement pathway opsonization by group A streptococcal M protein. J Infect Dis (1979) 1.97

A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. Am J Med (1996) 1.96

Acyclovir therapy for acute herpes zoster. Lancet (1982) 1.95

Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV. Infect Immun (1977) 1.92

Evaluation of public health preschool child developmental screening: the process and outcomes of a community program. Am J Public Health (1987) 1.91

Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun (1995) 1.91

The jejunal cellular infiltrate in coeliac disease complicated by lymphoma. Gut (1974) 1.90

Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med (1983) 1.90

Therapy of herpes zoster with oral acyclovir. Am J Med (1988) 1.89

Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals. J Clin Microbiol (1990) 1.88

A comparison of capitated and fee-for-service Medicaid reimbursement methods on pregnancy outcomes. Health Serv Res (1998) 1.86

Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet (1981) 1.86

Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers. Lancet (1977) 1.85

Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. JAMA (1987) 1.84

Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications. Ann Intern Med (1989) 1.84

Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis (1998) 1.83

Antibodies to cell wall peptidoglycan of Staphylococcus aureus in patients with serious staphylococcal infections. J Infect Dis (1981) 1.83

Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83

Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest (1981) 1.82

Pancreatic trauma: a review. Surgery (1972) 1.81

A prospective, randomised study of endoscopy and radiology in acute upper-gastrointestinal-tract bleeding. Lancet (1977) 1.81

Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science (1966) 1.81

Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes. J Clin Pathol (1978) 1.80

Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79

Chemiluminescence response of human leukocytes: influence of medium components on light production. Infect Immun (1977) 1.77

Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus. J Clin Microbiol (2007) 1.77

Transmission of hepatitis B virus in clinical laboratory areas. J Infect Dis (1979) 1.77

Family tension in the search for a kidney donor. JAMA (1971) 1.77

Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol (1990) 1.76

Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med (1988) 1.75

Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg (1990) 1.74

Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci U S A (1996) 1.71

Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet (1972) 1.71

Reactive nitrogen intermediates suppress the primary immunologic response to Listeria. J Immunol (1993) 1.69

Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology (2000) 1.69

Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes. Biochem Biophys Res Commun (1990) 1.67

A study of the cellular infiltrate of the proximal jejunal mucosa in ulcerative colitis and Crohn's disease. Gut (1975) 1.66

Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65

Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes. Infect Immun (1976) 1.63

Celiac disease and malignancy. Medicine (Baltimore) (1980) 1.63